Targeted Therapies Forum 2022: Dr. Aakash Desai, Hematology/Oncology Fellow, Mayo Clinic, Rochester, MN, and Dr. Fred R Hirsch, Executive Director, Center for Thoracic Oncology at Mount Sinai; Joe Lowe and Lewis Price Professor of Medicine, Icahn School of Medicine; Associate Director, Biomarker Discovery for TCI, Questions and answers morning session.
In this video, Dr. Fred Hirsch discusses which patients should receive NGS.
We thank our sponsors for this year’s support! #Novartis #Janssen #Blueprintmedicine #TakedaOncology #Astrazeneca #LillyOncology #genentech
For more, please visit http://cancerGRACE.org/.
To join the conversation, visit https://cancergrace.org/forum.